![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Acs Dobfar S.p.a. Tribiano It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Clindamycin phosphate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-025 - Rev 01
This Chemical Type CEP, issued on June 15, 2007, remains in force until January 16, 2012, ensuring its reliability within the pharmaceutical industry.
Substance Number 996 associated with this CEP further emphasizes